Balanced news tone
News Sentiment
ZURA sentiment intelligence
Zura Bio Limited Class A Ordinary Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
36 relevant articles
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-1.2% over one week, +38.1% over four weeks, trend inactive, and materially above fair value.
What's Going on With Zura Bio Stock Wednesday? - Zura Bio (NASDAQ:ZURA)
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
84/100 classification
One-week reaction
-1.2%
Price digesting
Trend fit
Trend inactive
38.1% over four weeks
Fair value
35.1%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
5
Neutral
29
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Industry context
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Zura Bio (ZURA) CEO awarded options on 894,000 Class A shares
Zura Bio Ltd. (ZURA) CEO Sandeep Chidambar Kulkarni was granted options on 894,000 Class A Ordinary Shares. These options have an exercise price of $6.03 per share and expire on April 1, 2036. The options will vest one-fourth on April 1, 2027, with the remainder vesting quarterly
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2026 22:10
- Source
- Stock Titan
Seeking Alpha
Direct company coverage
Zura Bio: Momentum Is Real, But TibuSHIELD Needs To Deliver (NASDAQ:ZURA)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Mar 2026 07:00
- Source
- Seeking Alpha
TradingView
Industry context
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Business Wire
Direct company coverage
Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Feb 2026 08:00
- Source
- Business Wire
Stock Titan
Direct company coverage
CEO shake-up at Zura Bio (NASDAQ: ZURA) with new director added
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jan 2026 08:00
- Source
- Stock Titan